FIVE YEARS' EXPERIENCE WITH IODINE-125 THERAPY OF GRAVES' DISEASE
- 13 July 1974
- journal article
- Published by Elsevier in The Lancet
- Vol. 304 (7872) , 74-77
- https://doi.org/10.1016/s0140-6736(74)91636-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Rapid Radioimmunoassay for Both T4and T3in the Same Sample of Human SerumJournal of Clinical Endocrinology & Metabolism, 1974
- Low-Dosage131I Therapy of Thyrotoxicosis (Diffuse Goiters)New England Journal of Medicine, 1974
- RESULTS OF TREATING 297 THYROTOXIC PATIENTS WITH 125IThe Lancet, 1973
- The Significance of Triiodothyronine (T3) in Maintenance of Euthyroid Status after Treatment of HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 1971
- EUTHYROIDISM AFTER HYPOTHYROIDISM FROM IODINE-125 THERAPYThe Lancet, 1971
- LONG-TERM RESULTS WITH IODINE-125 TREATMENT FOR TOXIC DIFFUSE GOITREThe Lancet, 1970
- Microscopic dose distribution from125I in the toxic thyroid gland and its relation to therapyThe British Journal of Radiology, 1970
- Classification of the Eye Changes of Graves' DiseaseJournal of Clinical Endocrinology & Metabolism, 1969
- Treatment of hyperthyroidism with sodium iodide I-131JAMA, 1966
- Incidence of Hypothyroidism and Recurrences Following I131 Treatment of HyperthyroidismActa Radiologica, 1961